I-MAK co-director and co-founder Tahir Amin expresses optimism about WHO’s move to expand generic licensing for Sovaldi to dozens of countries.
I-MAK co-director and co-founder Tahir Amin expresses optimism about WHO’s move to expand generic licensing for Sovaldi to dozens of countries.
Partner with us now to build
a more just and equitable
medicine system for all.